Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,756
Closed -$544K 451
2025
Q3
$544K Sell
16,756
-4,483
-21% -$160K 0.1% 262
2025
Q2
$875K Buy
21,239
+10,294
+94% +$398K 0.1% 238
2025
Q1
$457K Buy
10,945
+3,892
+55% +$202K 0.05% 335
2024
Q4
$413K Buy
+7,053
New +$417K 0.05% 281
2024
Q3
Sell
-18,454
Closed -$1.18M 453
2024
Q2
$1.18M Buy
+18,454
New +$1.39M 0.14% 195
2023
Q4
Sell
-10,901
Closed -$679K 449
2023
Q3
$679K Buy
+10,901
New +$733K 0.06% 296
2021
Q3
Sell
-8,636
Closed -$656K 427
2021
Q2
$656K Buy
8,636
+7,592
+727% +$530K 0.12% 210
2021
Q1
$67K Sell
1,044
-496
-32% -$29.8K 0.02% 493
2020
Q4
$83K Buy
1,540
+881
+134% +$42.2K 0.01% 703
2020
Q3
$26K Buy
+659
New +$27.5K 0.02% 539

Other funds holding BRKR

FORA Capital's BRKR Position: Q4 2025 in Review

FORA Capital sold out of Bruker (BRKR) in Q4 2025, closing a stake of 16,756 shares — an estimated $544K sold.

FORA Capital first reported a position in BRKR in Q3 2020 and held it in 10 quarters. The position peaked at $1.18M in Q2 2024. 355 funds tracked by Wall St. Rank hold BRKR as of Q4 2025.

  • FORA Capital reported no remaining Bruker position as of Q4 2025 after selling out during the quarter.
  • FORA Capital sold 16,756 Bruker shares in Q4 2025, an estimated $544K.
  • FORA Capital first reported a position in Bruker in Q3 2020 and held it in 10 quarters.
  • FORA Capital's Bruker position peaked at $1.18M in Q2 2024.
  • 355 funds tracked by Wall St. Rank held Bruker as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.